AB Science

Stocks

AB

FR0010557264

Market Closed - Euronext Paris 09:25:00 23/10/2026 pm IST			5-day change	1st Jan Change
0.5490 ^EUR	+1.10%		+1.10%	-64.26%

09/10	AB Science S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
05/10	Weekly earnings calendar: PepsiCo kicks off the quarterly marathon

Transcript : AB Science S.A. - Special Call

Published on 10/16/2025 at 07:21 pm IST - Modified on 10/24/2025 at 10:36 pm IST

S&P Capital IQ

Presenter Speech
Alain Moussy (Executives)

Good morning, and good afternoon for the participant to our web conference organized by AB Science. About an update of the clinical development of our asset

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

Latest news about AB Science

09/10	AB Science S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
05/10	Weekly earnings calendar: PepsiCo kicks off the quarterly marathon
01/10	Certain Ordinary Shares of AB Science S.A. are subject to a Lock-Up Agreement Ending on 1-OCT-2026.	CI
29/09	AB Science Reports Good Clinical Practice Inspection from Authorities in France, Denmark, Greece	MT
29/09	AB Science S.A. Considers Adapted Development Plan For AB8939 And Masitinib Clinical Studies	CI
11/09	Certain Ordinary Shares of AB Science S.A. are subject to a Lock-Up Agreement Ending on 11-SEP-2026.	CI
17/08	AB Science completes settlement and delivery of its private placement
10/08	AB Science Wraps Up EUR14 Million Private Placements	MT
10/08	AB Science raises €14.2m
13/07	AB Science to Discontinue Three Masitinib-related Clinical Studies	MT
10/07	AB Science streamlines its portfolio and refocuses on two molecules
10/07	AB Science SA Provides Update on Clinical Program, Suspends Non-Priority Clinical Trials and Focuses on Ab8939 and Masitinib Programs	CI
08/07	Stéphane Ledermann takes the helm at AB Science as CEO
07/07	AB Science S.A. Announces Board Changes	CI
07/07	AB Science S.A. Announces CEO Changes	CI

Chart AB Science

Duration

Period

AB: Dynamic Chart

Company Profile

Sector

More about the company

Income Statement and Estimates

Projected Income Statement - Annual - AB Science

More financial data